Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Histopathology|July 17, 2001
Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre)F Sandra, N Nakamura, T Mitsuyasu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Improved survival for patients with AIDS-related Kaposi's sarcomaS A Miles, H Wang, R Elashoff, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|May 11, 2001
Growth characteristics of ameloblastoma involving the inferior alveolar nerve: a clinical and histopathologic studyN Nakamura, T Mitsuyasu, Y Higuchi, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcomaD Aboulafia, S A Miles, S R Saks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2005
Quality of life in a clinical trial of highly active antiretroviral therapy alone or with intravenous or subcutaneous interleukin-2 administrationBarbara K Martin, Albert W Wu, Rebecca Gelman, et al.
Cancer|April 15, 1986
Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapyR T Mitsuyasu, J M Taylor, J Glaspy, et al.
Nihon Seikeigeka Gakkai Zasshi|March 1, 1981
[Roentgenographical examination on the tilted angle of the scapula in the resting position (author's transl)]T Torisu, S Himeno, T Mitsuyasu, et al.
Cancer|February 1, 1987
Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A)P A Volberding, R T Mitsuyasu, J P Golando, et al.
The American Journal of Medicine|December 1, 1986
Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test resultsR Afrasiabi, R T Mitsuyasu, P Nishanian, et al.
Stem Cells International|July 1, 2011
Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons LearntRonald T Mitsuyasu, Jerome A Zack, Janet L Macpherson, et al.
Pageof 12